Package Leaflet: Information for the User
Enantyum 12.5 mg film-coated tablets
dexketoprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Enantyum is a pain reliever belonging to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat pain of mild to moderate intensity, such as muscle or joint pain, menstrual pain (dysmenorrhea), toothache.
Do not take Enantyum:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Enantyum
Infections
Dexketoprofen may hide the signs of an infection, such as fever and pain. Consequently, this medicine may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and in bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
During chickenpox, it is recommended to avoid the use of this medicine.
Children and adolescents
This medicine has not been studied in children and adolescents. Therefore, safety and efficacy have not been established, and the product should not be used in children and adolescents.
Using Enantyum with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, including those obtained without a prescription. There are some medicines that should not be taken together and others that may need a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medicine, you are taking any of the following medicines:
Not recommended combinations:
Combinations that require caution:
Combinations to be taken into account:
If you have any doubts about taking other medicines with Enantyum, consult your doctor or pharmacist.
Taking Enantyum with food and drinks:
Take the tablets with a sufficient amount of water. Take the tablets with food, as this helps to reduce the risk of suffering from adverse effects in the stomach or intestine. However, in case of acute pain, take the tablets on an empty stomach; i.e., at least 30 minutes before meals, as this allows the medicine to act a little faster.
Pregnancy, breastfeeding, and fertility
Do not take this medicine during the last three months of pregnancy or during breastfeeding. It may cause kidney and heart problems in your fetus. It may affect your and your baby's tendency to bleed and delay or prolong labor more than expected.
Do not take Enantyum during the first six months of pregnancy unless it is clearly necessary and as indicated by your doctor. If you need treatment during this period or while trying to become pregnant, you should take the minimum dose for the shortest possible time.
From the 20th week of pregnancy, Enantyum may cause kidney problems in your fetus if taken for more than a few days, which may cause low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional checks.
The use of this medicine is not recommended while trying to conceive or while studying a fertility problem.
Regarding the potential effects on female fertility, see also section 2, "Warnings and precautions".
Driving and using machines
This medicine may slightly affect your ability to drive and use machines, as it may cause drowsiness or dizziness as side effects of treatment. If you notice these effects, do not use machines or drive until these symptoms disappear. Ask your doctor for advice.
Enantyum contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; i.e., it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The dose of this medicine that you need may vary, depending on the type, intensity, and duration of the pain. Your doctor will indicate how many tablets you should take per day and for how long.
The lowest effective dose should be used for the shortest duration necessary to relieve the symptoms. If you have an infection, consult a doctor without delay if the symptoms (such as fever and pain) persist or worsen (see section 2).
Generally, the recommended dose is 1 tablet (12.5 mg of dexketoprofen) every 4-6 hours, not exceeding 6 tablets per day (75 mg).
If you are an elderly patient or suffer from kidney or liver disease, it is recommended to start therapy with a maximum of 4 tablets per day (50 mg).
In elderly patients, this initial dose may be increased later according to the general recommended dose (75 mg of dexketoprofen) if the medicine has been well tolerated.
If your pain is intense and you need quick relief, take the tablets on an empty stomach (at least 30 minutes before meals) as they will be absorbed more easily (see section 2 "Taking Enantyum with food and drinks").
Use in children and adolescents
This medicine should not be used in children and adolescents (under 18 years of age).
If you take more Enantyum than you should
If you have taken too much medicine, inform your doctor or pharmacist immediately or go to the emergency department of your nearest hospital. Please remember to always carry the medicine package or this leaflet with you.
If you forget to take Enantyum:
Do not take a double dose to make up for forgotten doses. Take the next dose when it is due (according to section 3 "How to take Enantyum").
If you have doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The possible side effects are listed below according to their frequency.
Common side effects (may affect up to 1 in 10 people):
Nausea and/or vomiting, mainly pain in the upper abdominal quadrant, diarrhea, digestive disorders (dyspepsia).
Uncommon side effects (may affect up to 1 in 100 people):
Dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, inflammation of the stomach wall (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feverish sensation, and chills, general malaise.
Rare side effects (may affect up to 1 in 1,000 people):
Peptic ulcer, perforation of peptic ulcer, or gastrointestinal bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention, and peripheral edema (e.g., swelling of the ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood tests), liver cell damage (hepatitis), acute kidney failure.
Very rare side effects (may affect up to 1 in 10,000 people):
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin ulcers, mouth ulcers, eye ulcers, or genital ulcers (Stevens-Johnson syndrome and Lyell syndrome), swelling of the face or swelling of the lips and throat (angioedema), difficulty breathing due to narrowing of the airways (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis, blurred vision, tinnitus (ringing in the ears), sensitive skin, sensitivity to light, itching, kidney problems. Decreased number of white blood cells (neutropenia), decreased number of platelets (thrombocytopenia).
Tell your doctor immediately if you notice any gastrointestinal side effects at the start of treatment (e.g., stomach pain or bleeding), if you have previously suffered from these side effects due to prolonged treatment with anti-inflammatory drugs, and especially if you are elderly.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesion inside the mouth or on the genitals, or any other sign of allergy.
During treatment with non-steroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in the ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like this may be associated with a small increased risk of suffering from a heart attack ("myocardial infarction") or a stroke ("cerebrovascular accident").
In patients with immune system disorders that affect connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory medicines may rarely cause fever, headache, and neck stiffness.
The most commonly observed side effects are of a gastrointestinal nature. Peptic ulcers, perforation, or gastrointestinal bleeding may occur, sometimes fatally, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, inflammation of the stomach wall (gastritis) has been observed.
As with other NSAIDs, hematological reactions (purpura, aplastic anemia, and hemolytic anemia, and more rarely agranulocytosis and bone marrow hypoplasia) may occur.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the blister. The expiration date is the last day of the month indicated.
Do not store above 30°C. Store the blisters in the original packaging to protect them from light.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines at the pharmacy's SIGRE Point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Enantyum:
Tablet core: corn starch, microcrystalline cellulose, sodium carboxymethylcellulose, glycerol distearate.
Coating: dry lacquer (composed of hypromellose, titanium dioxide, macrogol 6000), propylene glycol.
Appearance of Enantyum and packaging contents:
Coated tablets, white, round, with convex sides and beveled edges, presented in blisters available in packages containing 10, 20, 30, 40, 50, and 500 coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder:
LABORATORIOS MENARINI, S.A.
Alfons XII, 587 - Badalona (Barcelona) Spain
Manufacturer:
LABORATORIOS MENARINI, S.A.
Alfons XII, 587 - Badalona (Barcelona) Spain
or
Via Campo di Pile s/n – L’AQUILA – Italy
This medicine is authorized in the member states of the European Economic Area under the following names:
Spain (EMR): Enantyum
Date of the last revision of this prospectus:August/2023
Other sources of information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of ENANTYUM 12.5 mg TABLETS in October, 2025 is around 2.5 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.